ANI Integrated

- The company is evaluating various options for fundraising, including potentially through corporate actions such as a rights issue, especially in the context of migrating to the main board. - As of now, there is no specific or firm commitment regarding any new debt or equity fundraising. - Management is considering these options to support further expansion but has not disclosed any definite plans or timelines.

- ANI Integrated Services Limited is primarily a services company, not manufacturing, so capital expenditure (capex) requirements are comparatively very low. - Planned capex mainly focuses on creating basic infrastructure necessary for service delivery. - No mention of any large or strategic capital investments or expansions requiring significant capex. - The company is concentrating on overseas business for growth, which supports cash flow and working capital without heavy capex. - Focus remains on organic growth via expanding services and geographical presence, especially in Middle East and Southeast Asia. - No specific disclosures about any future strategic investments or major capex have been provided in the call.

- ANI Integrated Services Limited expects at least 20-25% revenue growth in FY25. - The company aims to maintain 20% year-on-year revenue growth for the next three financial years. - Overseas sales are projected to increase by 40-50% compared to the previous year. - Strong order pipelines in Middle East (Saudi Arabia) and Southeast Asia (Malaysia, Indonesia, Vietnam) support international expansion. - Growth driven by repeat customers, who contribute around 80% of business. - Domestic expansion focuses on pharmaceuticals, food sectors, and infrastructure projects. - The company anticipates better margins, particularly from overseas operations. - Overall, ANI is optimistic about top-line growth continuing at a solid pace, with bottom-line profits expected to grow even faster than revenue.

- ANI Integrated Services expects revenue growth of at least 20-25% for FY25 and the coming years, with a consistent minimum of 20% year-on-year growth supported largely by repeat customers (80% of business). - Net profit for the current year is projected to grow by approximately 60-70%, with some optimism about continuing the strong upward trend. - EBITDA margins are expected to improve over the previous year, driven by better margins in overseas markets compared to domestic markets. - Overseas business and sectors like pharmaceuticals and food domestically are contributing positively to margins and profit growth. - Strong performance in Q1 FY25 and expansion in international markets (Middle East, Southeast Asia, Africa) indicate a better trend for top-line and bottom-line growth. - Management aims for continual margin improvement and operational excellence supporting earnings growth. - No specific EPS guidance was provided but the profit growth and margin improvement imply positive EPS momentum.

- The company has a strong order pipeline with good orders in the pipeline for the next 2-3 years. - Navin Korpe mentioned that, post-COVID, business focus has returned to Africa and the Middle East, with subsidiaries set up there and active business operations. - For FY25, the company expects revenue growth of more than 20-25%, indicating a healthy order book visibility. - Overseas sales are expected to be 40-50% higher than the previous year. - The project division has long-duration projects that require initial investments but eventually provide margins, contributing significantly to the order book. - The company is engaged with reputed clients like Technip, L&T, IOCL, HPCL, Nestle, Reliance, and others across various projects including new refineries and expansion projects.